Related Experiment Video
Updated: Dec 19, 2025
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
COVID-19: Loss of bridging between innate and adaptive immunity?
Vishal U S Rao1, Gururaj Arakeri1, Anand Subash1
1Department of Head and Neck Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India.
Insights
Children show distinct responses to COVID-19, appearing less susceptible to severe illness. Understanding these differences in the immune system could reveal new treatments for coronavirus disease 2019.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- Coronavirus disease 2019 (COVID-19) has become a global pandemic.
- Observed variations in COVID-19 severity across different age demographics.
- Limited data exists on pediatric COVID-19 cases, but initial findings suggest reduced susceptibility to severe outcomes.
Purpose of the Study:
- To investigate the unique characteristics of COVID-19 in children.
- To explore the potential link between these characteristics and the human immune system's response.
- To identify potential therapeutic strategies for COVID-19 based on immune system insights.
Main Methods:
- Analysis of existing epidemiological data on COVID-19 across age groups.
- Review of immunological studies related to viral infections in pediatric populations.
- Hypothetical modeling of immune system interactions in COVID-19.
Main Results:
- Children appear to exhibit a lower susceptibility to severe COVID-19 compared to adults.
- Distinct immune responses in children may offer insights into protective mechanisms.
- A potential disruption in the bridging mechanism between innate and adaptive immunity is hypothesized.
Conclusions:
- The differential behavior of COVID-19 in children warrants further investigation.
- Understanding pediatric immune responses could be key to developing effective COVID-19 treatments.
- Targeting the innate-adaptive immunity bridge may represent a novel therapeutic approach for COVID-19.
Abstract:
COVID-19 has spread to most countries in the world. However, there are some striking differences in how COVID-19 is behaving in different age groups. While data on COVID-19 is limited, children appear to be less susceptible to severe disease. These unique characteristics may be considered as a potential link to understanding the immune system and response in COVID-19 and lead to an effective cure to the disease. We suggest a possible role of loss of bridging between innate and adaptive immunity in COVID-19 and a potential treatment modality also discussed.
More Related Videos
Related Concept Videos
01:21Introduction to Innate and Adaptive Immunity
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
01:40Cell-mediated Immune Responses
01:20Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:38What is the Immune System?
01:26Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...